Therapeutical neoangionesis;Therapeutische neoangiogenese

Zeitschrift fur Kardiologie

Volumn 88, Issue 4, 1999, Pages 241-244

  Schmeisser A ^a   Daniel, W G ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; COLLATERAL CIRCULATION; GENE THERAPY; GENE TRANSFER; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CAPILLARIES; COLLATERAL CIRCULATION; CORONARY CIRCULATION; HUMANS; MYOCARDIAL REVASCULARIZATION; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 17144463248     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050282     Document Type: Review

References (26)

1. Aiello LP, Avery RL, Arrig PG (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487
2. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W (1997) Monocyte activation in angiogenesis and collateral growth in rabbit hindlimb. J Clin Invest 101:40-50
3. Asahara T, Chen D, Takahasi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM (1998) Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF induced postnatal neovascularisation. Circ Res 83:233-240
4. Asahara T, Takahasi T, Kalka C, Masuda H, Chen D, Siver M, Isner J (1998) A novel function for VEGF: Mobilisation of bone marrow-derived endothelial progenitor cells. Circulation 98:I-605 (abstract)
5. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123
6. Bellamy WT, Richter L, Frutiger Y, Grogan TM (1999) Expression of vascular endothelial growth factor and its receptors in haematopoietic malignancies. Cancer Res 59:728-733
7. Folkman J (1971) Tumor angiogenesis: Therapeutic implications: N Engl J Med 285:1182-1186
8. Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763
9. Folkman J (1998) Therapeutic angiogenesis in ischemic limbs. Circulation 97:1108-1110
10. Gross JL, Herblin WF, Dusak BA, Czerniak P, Diamond M, Dexter L (1990) Modulation of solid growth in vivo by bFGF. Proc Am Assoc Cancer Res 31:I-469 (abstract)
11. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
12. Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Rothman JM, Borbas ER, McCluskey ER (1998) Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial. J Am Cull Cardiol 31:65a (abstract)
13. 165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804
14. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewksi C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
15. Pepper MS (1997) Manipulating angiogenesis: From basic science to the bedside. Arterioscler Thromb Vasc Biol 17:605-619
16. Peters KG (1998) Vascular endothelial growth factor and the angiopoietins working together to build a better blood vessel. Circ Res 83:342-343
17. Riesau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
18. 121 cDNA adenovirus-mediated angiogenesis gene therapy in conjunction with coronary bypass surgery. Circulation 98:I-321 (abstract)
19. Schaper W, Ito WD (1996) Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911-919
20. Schumacher B, Pecher P, von Specht BU, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97:645-650
21. SoRelle R (1998) Two sides of the same coin: Stop angiogenesis for cancer and encourage it for coronary artery disease. Circulation 98:383-384
22. SoRelle R (1999) From global to microscopic views of cardiovascular disease. Circulation 99:3-5
23. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
24. Vale PR, Losordo DW, Symes JF, Isner JM (1998) Gene therapy for myocardial angiogenesis. Circulation 98:I-322 (abstract)
25. Waltenberger J (1997) Modulation of growth factor action: Implications for the treatment of cardiovascular disease. Circulation 96:4083-4094
26. Ware JA, Simons M (1997) Angiogenesis in ischemic heart disease. Nature Medicine 3:158-164